Related references
Note: Only part of the references are listed.Spinal Cord Injury Causes Brain Inflammation Associated with Cognitive and Affective Changes: Role of Cell Cycle Pathways
Junfang Wu et al.
JOURNAL OF NEUROSCIENCE (2014)
Comparing the Predictive Value of Multiple Cognitive, Affective, and Motor Tasks after Rodent Traumatic Brain Injury
Zaorui Zhao et al.
JOURNAL OF NEUROTRAUMA (2012)
Accelerated Human Mutant Tau Aggregation by Knocking Out Murine Tau in a Transgenic Mouse Model
Kunie Ando et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans
John R. Cirrito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Traditional Chinese medicines and Alzheimer's disease
Tzong-Yuan Wu et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2011)
Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?
Gislaine Z. Reus et al.
BRAIN RESEARCH BULLETIN (2010)
Amyloid beta and APP as biomarkers for Alzheimer's disease
Henrik Zetterberg et al.
EXPERIMENTAL GERONTOLOGY (2010)
A Flavonol Glycoside, Isolated From Roots of Panax notoginseng, Reduces Amyloid-beta-Induced Neurotoxicity in Cultured Neurons: Signaling Transduction and Drug Development for Alzheimer's Disease
Roy C. Y. Choi et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Memantine Lowers Amyloid-beta Peptide Levels in Neuronal Cultures and in APP/PS1 Transgenic Mice
George M. Alley et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (Aβ) peptide in the human neuroblastoma cells
Balmiki Ray et al.
NEUROSCIENCE LETTERS (2010)
Structural and functional diversity of viral IRESes
Laurent Balvay et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2009)
Bridging IRES elements in mRNAs to the eukaryotic translation apparatus
Kerry D. Fitzgerald et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2009)
Translation Initiation of the Human Tau mRNA Through an Internal Ribosomal Entry Site
Bethany L. Veo et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Amyloid-beta, Tau, and Dementia
Akihiko Takashima
JOURNAL OF ALZHEIMERS DISEASE (2009)
Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies
Jozef Hanes et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Cold-Induced Exodus of Postsynaptic Proteins From Dendritic Spines
Hui-Hsuan Cheng et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors
Kate E. Gilling et al.
NEUROPHARMACOLOGY (2009)
DUAL ACTION OF MEMANTINE IN ALZHEIMER DISEASE: A HYPOTHESIS
Tzong-Yuan Wu et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2009)
Amantadine as a regulator of internal ribosome entry site
Ying-ju Chen et al.
ACTA PHARMACOLOGICA SINICA (2008)
Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease
Colleen E. Jackson et al.
ALZHEIMERS & DEMENTIA (2008)
Tau isoform expression and regulation in human cortical neurons
Atul Deshpande et al.
FASEB JOURNAL (2008)
Regulating amyloid precursor protein synthesis through an internal ribosomal entry site
Monique E. Beaudoin et al.
NUCLEIC ACIDS RESEARCH (2008)
Memantine agonist action at dopamine D2High receptors
Philip Seeman et al.
SYNAPSE (2008)
Assembly of two distinct dimers and higher-order oligomers from full-length tau
Naruhiko Sahara et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
A century of Alzheimer's disease
Michel Goedert et al.
SCIENCE (2006)
100 years and counting: Prospects for defeating Alzheimer's disease
Erik D. Roberson et al.
SCIENCE (2006)
Cognitive dysfunction induced by sequential injection of amyloid-β and ibotenate into the bilateral hippocampus;: protection by memantine and MK-801
Shizuo Nakamura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine
Muhammad Omar Chohan et al.
FEBS LETTERS (2006)
Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury
DL Brody et al.
EXPERIMENTAL NEUROLOGY (2006)
Mechanism of action of memantine
JW Johnson et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
The chemical biology of clinically tolerated NMDA receptor antagonists
Huei-Sheng Vincent Chen et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Development of a bi-cistronic baculovirus expression vector by the Rhopalosiphum padi virus 5′ internal ribosome entry site
YJ Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Internal ribosome entry sites in cellular mRNAs: Mystery of their existence
AA Komar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
High-efficiency protein expression mediated by enterovirus 71 internal ribosome entry
JC Lee et al.
BIOTECHNOLOGY AND BIOENGINEERING (2005)
β-Amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor α and NMDA receptors
AM Floden et al.
JOURNAL OF NEUROSCIENCE (2005)
Tau alteration and neuronal degeneration in tauopathies: mechanisms and models
R Brandt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Cellular internal ribosome entry segments:: structures, trans-acting factors and regulation of gene expression
M Stoneley et al.
ONCOGENE (2004)
Preferential translation of internal ribosome entry site-containing mRNAs during the mitotic cycle in mammalian cells
XL Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration
L Liang et al.
FEBS LETTERS (2004)
Cap-dependent and cap-independent translation in eukaryotic systems
WC Merrick
GENE (2004)
The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease
MA Rogawski et al.
CNS DRUG REVIEWS (2003)
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence
W Danysz et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Interleukin-6, β-amyloid peptide and NMDA interactions in rat cortical neurons
ZH Qiu et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Isoforms changes of tau protein during development in various species
H Takuma et al.
DEVELOPMENTAL BRAIN RESEARCH (2003)
In vivo activity of Rhopalosiphum padi virus internal ribosome entry sites
LL Domier et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Share Paper
